Clinical Trials Logo

Filter by:
NCT ID: NCT01656863 Not yet recruiting - Attitudes Clinical Trials

Oral Rehydration Therapy in Children With Mild to Moderate Dehydration

Start date: August 2012
Phase: N/A
Study type: Observational

The purpose of this study is to determine parental attitudes towards oral rehydration therapy for children with mild to moderate dehydration.

NCT ID: NCT01655472 Not yet recruiting - Clinical trials for Foetal Differences Between Healthy and Schizophernic Parents

Schizophrenia Imaging

Start date: July 2012
Phase: N/A
Study type: Interventional

Schizophrenia is a common disorder with a lifetime prevalence of about 1%.Genetic studies strongly suggest a genetic component to the inheritance of schizophrenia. Structural neuroimaging studies have provided consistent evidence for brain abnormalities in schizophrenia. The timing of brain abnormalities in schizophrenia has not been determined yet. The investigators hypothesize that brain structural changes can be detected in neonatal life. The investigators hypothesize that offspring of schizophrenic patients will have higher rates of brain structural changes in the neonatal period. The investigators propose to study early development of fetuses in offspring of patients with schizophrenia. The study is a multi-center prospective trial.

NCT ID: NCT01655355 Not yet recruiting - Clinical trials for Revision of the Hip Joint

Revision of the Hip Joint - Prospective Study

Start date: n/a
Phase: N/A
Study type: Observational

Between the years 1999-2011 70 patients went through a revision of the hip joint(revision after not successful Total or Partial Hip Replacement). During the revision the Acetabular implant was found to be stable and it was decided not to replace it. The polyethylene insert was replaced and was fixated using a cement. Our purpose is to evaluate the physical condition of these patients.

NCT ID: NCT01654900 Not yet recruiting - Quality of Life Clinical Trials

Mid-term Survival and Quality of Life of Elderly Patients Undergoing Open Heart Surgery

Start date: October 2012
Phase: N/A
Study type: Observational

The purposes of the investigators study is to examine the overall survival and quality of life in elderly patients (> 75 years) undergoing open heart surgery at Hadassah medical center between 2008-2011. All alive patients will be phone interviewed using the 36-item short form health survey. Results will be compared to similar health survey results (36-SF)obtained from a group of Israeli adults who had no open heart surgery (controlled group). The investigators hypothesize that elderly patients achieve improvement in quality of life after open heart surgery with acceptable operative morbidity and mortality.

NCT ID: NCT01652521 Not yet recruiting - Pleural Effusion Clinical Trials

Effects of Pleural Effusion Drainage on Respiratory System Mechanics

Start date: July 2012
Phase: N/A
Study type: Observational

The effects of pleural drainage on lung mechanics are unknown. Insertion of esophageal balloon will allow us to measure and assess pleural pressure, and thus assess any possible effects of pleural fluid drainage may have on lung mechanics.

NCT ID: NCT01650363 Not yet recruiting - Clinical trials for Patients Undergoing Open Heart Surgery

CAM in Post Surgical Management in Cardiothoracic Surgery

Start date: October 2012
Phase: Phase 3
Study type: Interventional

This is a randomized controlled clinical trial in which the combination of 4 different CAM modalities (Complementary & Alternative Medicine) will be applied during the postoperative period to patients undergoing open heart- or lung surgery and expected to be hospitalized for more than 5 days. Elective and Urgent surgical patients will be randomly assigned to a treatment - and to a control group. The treatment group will be treated with a combination of 4 different CAM modalities (Homeopathy, Osteopathy, and Acupuncture & Reflexology) . The control group will be treated with Homeopathic placebo medication. The main Outcome measurement in the study will be the Quality of recovery 40 questionnaire (QoR- 40) that will be filled out on postoperative days: 3, 5, and 7 respectively. Secondary outcome measurements will be Blood &Saliva Cortisol levels, DHES levels in the blood as surrogates of stress, IL-2 levels as measures of the immune system. Further parameters to be measured include: LOS (length of stay), Level of Pain, mobility, level of satisfaction, GI symptoms (nausea, first bowel movement), post-operative complications& side effects. All patients participating in the trial will sign an informed consent form . The trial is expected to be conducted over a period of 12 months. Prior to the trial a pilot study will be conducted on a group of 30 patients in order to determine the needed sample size for the trial.

NCT ID: NCT01649739 Not yet recruiting - Clinical trials for Pulmonary Arterial Hypertension

Vardenafil as add-on Therapy for Patients With Pulmonary Hypertension Treated With Inhaled Iloprost

Start date: September 2012
Phase: Phase 4
Study type: Interventional

Patients with pulmonary arterial hypertension (PAH) suffer from breathlessness, poor quality of life and inability to function, despite medical therapy Current consensus states that combination therapy with different classes of PAH-specific therapy is likely to bring additional benefit to PAH patients. In this study we plan to study how exercise performance changes when the phosphodiesterase inhibitor vardenafil is added to patients who remain symptomatic from PAH when treated with inhaled iloprost. Following baseline assessment, all Patients will start vardenafil 10 mg bid. If the drug is tolerated by the patients, after a two week period, up titration to 20 mg bid will be permitted, at the discretion of the investigators. According to treatment protocol up titration will be done carefully and whenever side effects will be reported up titration will be stopped or dosage will be decreased or stopped according to the investigator judgment. Systemic BP will be measured at baseline assessment. The patient will attend the clinic for the first dose monitoring (10 mg) and after up titration of the study drug to 20 mg. Systemic BP will be measured at baseline assessment. The patient will attend the clinic for the first dose monitoring (10 mg) and after up titration of the study drug to 20 mg. A fall in SBP of>30 mmHg will be considered significant or any smaller value at the discretion of the investigator. BP will be measured according to the following protocol. Pre-dose Immediately before administration of vardenafil. This will be timed approximately one hour prior to the next planned dose of iloprost. Pre-inhalation One hour post vardenafil dose, immediately prior to iloprost inhalation. Post-inhalation Immediately following completion of iloprost inhalation and every fifteen minutes for one hour. Prior to discharge Two hours following the iloprost. Later monitoring At all follow-up visits, BP will be measured. This is an open-label study to evaluate the safety and efficacy of adding higher doses of vardenafil to inhaled iloprost over 3 months.

NCT ID: NCT01647373 Not yet recruiting - Clinical trials for Rhegmatogenous Retinal Detachment

Axial Length Change in Eyes Treated by Silicone Sponge Scleral Buckling

Start date: July 2013
Phase: N/A
Study type: Observational

All existing medical literatue regarding axial length (AL) changes after scleral buckling surgery for retinal detachment, descibes changes after solid silicone buckling. In this hospital, the investigators use only silicone sponge buckling, which has different properties and a different buckle profile. there are no studies in the literature describing tha AL changes after sponge buckling, or whether the AL change is less or more than with solid silicone buckles. The investigators wish to determine whether the AL change profile with their silicone sponge is significantly different, and if so, whether this is clinically important in determining the better choice of buckle material to be preferred.

NCT ID: NCT01646801 Not yet recruiting - Clinical trials for Peripheral Arterial Disease

Study of NMB Drug Ejecting Balloon for Peripheral Arteries

Start date: January 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to demonstrate the Safety and effectiveness of the use of NMB's drug ejecting balloon for the treatment of de novo and restenotic lesions in peripheral arterial disease.

NCT ID: NCT01646788 Not yet recruiting - Clinical trials for Obstructive Lesions of Arteriovenous Dialysis Fistulae

Study of NMB Drug Ejecting Balloon for Arteriovenous Fistulae

Start date: January 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to demonstrate the safety and effectiveness of the use of NMB's percutaneous transluminal angioplasty (PTA) for the treatment of obstructive lesions of Arteriovenous (AV) Dialysis Fistulae/Grafts.